Sign In
Buy EDIT
$2.78
-0.0400 (-1.42%)
At Close: Jun 03, 2026
GameStop Lessons: Becoming a Savvy Investor with ETFs
03:52pm, Thursday, 11'th Feb 2021
As more young investors take up day trading, I have a recipe for long-term wealth creation
5 Best ETFs for Young Investors
07:15pm, Wednesday, 10'th Feb 2021
As more young investors take up day trading, I have an important recipe for long-term wealth creation.
Why Editas Medicine Stock Sank Today
04:42pm, Wednesday, 10'th Feb 2021
Investors reacted negatively to a major deal announced by Editas' former partner with another gene-editing biotech.
Better Buy: CRISPR Therapeutics vs. Editas Medicine
06:10am, Friday, 05'th Feb 2021
Which of these two hot gene therapy stocks is the better buy?
Editas Medicine (EDIT) Outpaces Stock Market Gains: What You Should Know
06:54pm, Thursday, 04'th Feb 2021
In the latest trading session, Editas Medicine (EDIT) closed at $63.18, marking a +1.64% move from the previous day.
Intellia, Editas: How Are Gene Editing Stocks Faring?
11:00am, Thursday, 28'th Jan 2021
Gene-editing technology is used to insert, edit, or delete a gene from an organism's genome, and shows promise in treating medical conditions ranging from cancer to rare genetic conditions. Our indica
The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF
08:21am, Wednesday, 27'th Jan 2021
One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.
Is Editas Medicine a Buy?
06:30am, Tuesday, 26'th Jan 2021
Could this maverick biotech discover the cure for several debilitating rare diseases?
Editas Medicine (EDIT) Stock Sinks As Market Gains: What You Should Know
06:48pm, Monday, 25'th Jan 2021
In the latest trading session, Editas Medicine (EDIT) closed at $65.47, marking a -0.44% move from the previous day.
Can Editas Medicine Stock Bounce Back After A 13% Drop In 5 Days?
08:00am, Monday, 25'th Jan 2021
Editas Medicine, a biotechnology company focused on developing treatments using gene editing technology, has plunged by 13% over the last 5 trading days, after the company stated its plans to issue 3.
Why I'm Betting Big on This 1 Megatrend
06:01am, Monday, 25'th Jan 2021
It's a big bet but not a big gamble.
Where to Invest $1 Million Right Now
07:10am, Sunday, 24'th Jan 2021
With a nest egg this sizable, you'll need to find more than one place to put your money so it keeps growing.
Sana Biotechnology Seeks $150 Million U.S. IPO
01:54pm, Friday, 22'nd Jan 2021
Sana Biotechnology Seeks $150 Million U.S. IPO
A Play on the Biggest Scientific Breakthrough of the Century
09:28am, Friday, 22'nd Jan 2021
There are only a handful of large, well-established gene editors with robust and mature therapy pipelines in the world today. Of those, one that stands out is a $4.8 billion biotechnology company by t
Why Editas Medicine, Inovio, Dyne, and CytomX Stocks Are Falling Today
12:00pm, Thursday, 21'st Jan 2021
All four biotechs announced the pricing of stock offerings.
